Punt CJA - Search Results

1

The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.

Bolhuis K, Bond MJG, Van Amerongen MJ, Komurcu A, Chapelle T, Dejong CHC, Engelbrecht MRW, Gerhards MF, Grünhagen DJ, van Gulik TM, Hermans JJ, De Jong KP, Kazemier G, Klaase JM, Kok NFM, Leclercq WKG, Liem MSL, van Lienden KP, Molenaar IQ, Neumann UP, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, May AM, Punt CJA, Swijnenburg RJ; Dutch Colorectal Cancer Group Liver Expert Panel. Bolhuis K, et al. Among authors: punt cja. Eur J Cancer. 2023 Apr;183:49-59. doi: 10.1016/j.ejca.2023.01.013. Epub 2023 Jan 31. Eur J Cancer. 2023. PMID: 36801606 Free article. Clinical Trial.

2

Biological therapy of colorectal cancer.

de Kleijn EM, Punt CJ. de Kleijn EM, et al. Eur J Cancer. 2002 May;38(7):1016-22. doi: 10.1016/s0959-8049(02)00057-6. Eur J Cancer. 2002. PMID: 11978526 Review.

3

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

Koopman M, Venderbosch S, van Tinteren H, Ligtenberg MJ, Nagtegaal I, Van Krieken JH, Punt CJ. Koopman M, et al. Eur J Cancer. 2009 Jul;45(11):1999-2006. doi: 10.1016/j.ejca.2009.04.017. Epub 2009 May 18. Eur J Cancer. 2009. PMID: 19457654

4

A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

Koopman M, Venderbosch S, Nagtegaal ID, van Krieken JH, Punt CJ. Koopman M, et al. Eur J Cancer. 2009 Jul;45(11):1935-49. doi: 10.1016/j.ejca.2009.04.023. Epub 2009 May 25. Eur J Cancer. 2009. PMID: 19473832 Review.

5

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.

Tol J, Dijkstra JR, Klomp M, Teerenstra S, Dommerholt M, Vink-Börger ME, van Cleef PH, van Krieken JH, Punt CJ, Nagtegaal ID. Tol J, et al. Eur J Cancer. 2010 Jul;46(11):1997-2009. doi: 10.1016/j.ejca.2010.03.036. Epub 2010 Apr 21. Eur J Cancer. 2010. PMID: 20413299 Clinical Trial.

6

The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.

Knijn N, Tol J, Koopman M, Werter MJ, Imholz AL, Valster FA, Mol L, Vincent AD, Teerenstra S, Punt CJ. Knijn N, et al. Eur J Cancer. 2011 Feb;47(3):369-74. doi: 10.1016/j.ejca.2010.10.006. Epub 2010 Nov 8. Eur J Cancer. 2011. PMID: 21067912 Clinical Trial.

7

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH, Punt CJ, Nagtegaal ID. Knijn N, et al. Br J Cancer. 2011 Mar 15;104(6):1020-6. doi: 10.1038/bjc.2011.26. Epub 2011 Mar 1. Br J Cancer. 2011. PMID: 21364579 Free PMC article.

8

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.

Simkens LH, Koopman M, Mol L, Veldhuis GJ, Ten Bokkel Huinink D, Muller EW, Derleyn VA, Teerenstra S, Punt CJ. Simkens LH, et al. Eur J Cancer. 2011 Nov;47(17):2560-7. doi: 10.1016/j.ejca.2011.06.038. Epub 2011 Jul 29. Eur J Cancer. 2011. PMID: 21803570 Free article. Clinical Trial.

9

Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Venderbosch S, de Wilt JH, Teerenstra S, Loosveld OJ, van Bochove A, Sinnige HA, Creemers GJ, Tesselaar ME, Mol L, Punt CJ, Koopman M. Venderbosch S, et al. Ann Surg Oncol. 2011 Nov;18(12):3252-60. doi: 10.1245/s10434-011-1951-5. Epub 2011 Aug 6. Ann Surg Oncol. 2011. PMID: 21822557 Free PMC article.

10

Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.

Mekenkamp LJ, Heesterbeek KJ, Koopman M, Tol J, Teerenstra S, Venderbosch S, Punt CJ, Nagtegaal ID. Mekenkamp LJ, et al. Eur J Cancer. 2012 Mar;48(4):501-9. doi: 10.1016/j.ejca.2011.12.004. Epub 2012 Jan 4. Eur J Cancer. 2012. PMID: 22226571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

410 results

Search Page